Shared Neoantigens
Shared Neoantigens is a class of tumor-specific antigens arising from recurrent somatic mutations that are identically present across multiple patients or tumor types, distinguished from private neoantigens by their occurrence in disparate individuals and potential for broad applicability in off-the-shelf neoantigen-targeted immunotherapies.
21
Publications
1.3K
Citations
267
Authors
88
Institutions
Publications per year
2017–2026
19
21
TSNAdb: A Database for Tumor-Specific Neoantigens from Immunogenomics Data Analysis
Jingcheng Wu, Wenyi Zhao, Binbin Zhou et al. · Genomics Proteomics & Bioinformatics · 2018 · 115 citations · Full text
Medicine, Immunology, Oncology +17
Pan-cancer proteogenomics expands the landscape of therapeutic targets
Sara R. Savage, Xinpei Yi, Jonathan T. Lei et al. · Cell · 2024 · 105 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 21
267
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 267
88
University of Copenhagen
Copenhagen, Denmark
2 h-index
5 publications
70 citations
Fudan University
Shanghai, China
2 h-index
4 publications
430 citations
Copenhagen University Hospital
Copenhagen, Denmark
2 h-index
11 publications
155 citations
Tongji University
Shanghai, China
1 h-index
4 publications
120 citations
University of Vienna
Vienna, Austria
1 h-index
2 publications
62 citations
Baylor College of Medicine
Houston, United States
1 h-index
13 publications
1.4K citations
University of South China
Hengyang, China
1 h-index
1 publications
78 citations
Iowa State University
Ames, United States
1 h-index
1 publications
115 citations
1–8 of 88
2 publications · 209 citations
2
h-index
1 publications · 115 citations
1
h-index
1 publications · 31 citations
1
h-index
1 publications · 105 citations
1
h-index
1 publications · 51 citations
1
h-index
1–5